Why the categorization of indexed effective orifice area is not justified for the classification of prosthesis-patient mismatch.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
09 2022
Historique:
received: 07 06 2020
revised: 08 10 2020
accepted: 20 10 2020
pubmed: 20 12 2020
medline: 18 8 2022
entrez: 19 12 2020
Statut: ppublish

Résumé

Although the impact of prosthesis-patient mismatch (PPM) on survival has been widely studied, there has been little debate about whether the current definition of PPM truly reflects hemodynamic obstruction. This study aimed to validate the categorization of indexed effective orifice area (EOAi) for the classification of PPM. In total, 2171 patients who underwent aortic valve replacement with a surgical stented bioprosthesis in 5 trials (CoreValve US High-Risk, SURTAVI [Surgical Replacement and Transcatheter Aortic Valve Implantation Trial], Evolut Low Risk, PERIGON [PERIcardial SurGical AOrtic Valve ReplacemeNt] Pivotal Trial for the Avalus valve, and PERIGON Japan) were used for this analysis. The echocardiographic images at the 1-year follow-up visit were evaluated to explore the association between EOAi and mean aortic gradient and its interaction with other patient characteristics, including obesity. In addition, different criteria of PPM were compared with reflect elevated mean aortic gradients (≥20 mm Hg). A relatively smaller exponential decay in mean aortic gradient was found for increasing EOAi, as the slope on the log scale was -0.83 versus -2.5 in the publication from which the current cut-offs for PPM originate. The accuracy of the American Society of Echocardiography, Valve Academic Research Consortium-2, and European Association of Cardiovascular Imaging definitions of PPM to reflect elevated mean aortic gradients was 49%, 57%, and 57%, respectively. The relation between EOAi and mean aortic gradient was not significantly different between obese and non-obese patients (P = .20). The use of EOAi thresholds to classify patients with PPM is undermined by a less-pronounced exponential relationship between EOAi and mean aortic gradient than previously demonstrated. Moreover, recent adjustment for obesity in the definition of PPM is not supported by these data.

Identifiants

pubmed: 33339597
pii: S0022-5223(20)33047-6
doi: 10.1016/j.jtcvs.2020.10.123
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

822-829.e6

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Michiel D Vriesendorp (MD)

Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: M.D.Vriesendorp@lumc.nl.

G Michael Deeb (GM)

Department of Cardiac Surgery, University of Michigan Health System-University Hospital, Ann Arbor, Mich.

Michael J Reardon (MJ)

Department of Cardiothoracic Surgery, Houston Methodist DeBakey Heart and Vascular Center, Houston, Tex.

Bob Kiaii (B)

Department of Cardiovascular and Thoracic Surgery, London Health Sciences Centre, London, Ontario, Canada.

Vinayak Bapat (V)

Department of Surgery, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, NY.

Louis Labrousse (L)

Medico-Surgical Department of Valvulopathies, CHU Hospital of Bordeaux, Bordeaux, France.

Vivek Rao (V)

Department of Cardiovascular Surgery, Toronto General Hospital, Toronto, Ontario, Canada.

Joseph F Sabik (JF)

Department of Surgery, University Hospitals, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Elizabeth Gearhart (E)

Department of Biostatistics, Medtronic, Minneapolis, Minn.

Robert J M Klautz (RJM)

Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: R.J.M.Klautz@lumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH